EVER IMMUNE
DEAD

Serial Number

79198170

Owner

GUSTAVE ROUSSY TRANSFERT

Filing Date

Aug 4, 2016

Add to watchlist:

No watchlists yet
View on USPTO

EVER IMMUNE Trademark

Serial Number: 79198170 • Registration: 5366762

EVER IMMUNE is a trademark filed by GUSTAVE ROUSSY TRANSFERT on August 4, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

GUSTAVE ROUSSY TRANSFERT (3 trademarks)

39 rue Camille Desmoulins

Entity Type: 33

EVERIMMUNE (2 trademarks)

39 rue Camille Desmoulins

Entity Type: 99

Trademark Details

Filing Date

August 4, 2016

Registration Date

January 2, 2018

Published for Opposition

October 17, 2017

Cancellation Date

July 19, 2024

Goods & Services

Computer programs for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; software for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; recorded computer programs regardless of the medium for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; pre-recorded magnetic, electronic, optical, magneto-optical data media, memory cards, CD-ROMs, digital videodisks featuring information on cancer; pre-recorded optical disks featuring information on cancer; pre-recorded magneto-optical disks featuring information on cancer; pre-recorded magnetic tapes featuring information on cancer; downloadable or non-downloadable software for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; computer programs and software used for the acquisition, visualization, processing, exploitation, annotation, storage, searching, dissemination and printing of all types of medical data, especially of images obtained by a radiographic means by X-ray, scanner, petscan, ultrasonography, magnetic resonance, tomography for the purpose of cancer screening, diagnosis or treatment, in the medical, surgical and health field and in cancer research; apparatus for recording, transmission and reproduction of sound or images; data processing equipment for processing information, computers

pharmaceutical products, namely, pharmaceutical preparations, medicines and vaccines for treatment and prevention of cancer

Medical services; hospital services; medical analyses namely, medical testing for diagnostic or treatment purposes; medical expertise services namely, medical diagnostic testing, monitoring, reporting and performing a diagnosis of cancer; health services namely, treatment of cancer; medical and surgical services; medical imaging, radiotherapy, brachytherapy and medical dosimetry services for treating cancer; medical diagnosis services namely, analysis and interpretation of images generated by x-ray apparatus, scanner, positron emission tomography (PET) scanner, magnetic resonance imaging scanner, ultrasound scanner; medical information services in the field of the fight against cancer, namely, information on cancer treatment

Surgical, medical, dental and veterinary apparatus and instruments namely, x-ray apparatus, scanner, positron emission tomography (PET) scanners, magnetic resonance imaging scanner, ultrasound scanner, radiotherapy treatment apparatus, artificial limbs, eyes and teeth; orthopedic articles namely, orthopedic implants, orthopedic bandages and splints, orthopedic braces; suture material

Scientific research services, namely cancer research, medical research services, research and development of new medical products, research in the fields of bacteriology, biology, chemistry; scientific information services in the field of the fight against cancer, clinical research, research and biology laboratories; research for new treatments and pharmaceutical products, vaccines, medicines against cancer

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Jul 4, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 14, 2025 INTS
INVALIDATION PROCESSED
Jun 14, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 19, 2025 INTR
CANCELLED SECTION 71
Jul 19, 2024 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Apr 13, 2024 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 2, 2023 REM3
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Oct 7, 2022 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 4, 2022 CRCV
CHANGE OF OWNER RECEIVED FROM IB
May 22, 2022 CHLD
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 6, 2020 TCCA
NEW REPRESENTATIVE AT IB RECEIVED
Jan 23, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 19, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 12, 2018 FICS
FINAL DISPOSITION PROCESSED
Apr 12, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 2, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 2, 2018 R.PR
NOTIFICATION PROCESSED BY IB
Oct 21, 2017 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2017 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 4, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 4, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 1, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 1, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 1, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 1, 2017 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 22, 2017 GNRN
NON-FINAL ACTION E-MAILED
Aug 22, 2017 GNRT
NON-FINAL ACTION WRITTEN
Aug 22, 2017 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jul 23, 2017 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 5, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 5, 2017 TROA
REFUSAL PROCESSED BY IB
Feb 3, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 13, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jan 13, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 31, 2016 RFCR
NON-FINAL ACTION WRITTEN
Dec 30, 2016 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Dec 29, 2016 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 24, 2016 RFCR
APPLICATION FILING RECEIPT MAILED
Dec 24, 2016 MAFR
NON-FINAL ACTION WRITTEN
Dec 23, 2016 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 15, 2016 REPR